We are live on ! Find out more
GMED icon

Globus Medical

408 hedge funds and large institutions have $5.72B invested in Globus Medical in 2023 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 132 increasing their positions, 164 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

625% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $3.61M

11% more funds holding in top 10

Funds holding in top 10: 910 (+1)

5% more capital invested

Capital invested by funds: $5.43B → $5.72B (+$289M)

0.15% less ownership

Funds ownership: 93.23%93.09% (-0.15%)

5% less funds holding

Funds holding: 431408 (-23)

20% less repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 164

22% less first-time investments, than exits

New positions opened: 51 | Existing positions closed: 65

Holders
408
Holders Change
-23
Holders Change %
-5.34%
% of All Funds
5.95%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.15%
New
51
Increased
132
Reduced
164
Closed
65
Calls
$26.2M
Puts
$3.61M
Net Calls
+$22.6M
Net Calls Change
+$12.3M
Name Holding Trade Value Shares
Change
Change in
Stake
FGAM
401
Financial Gravity Asset Management
Texas
$510 +$292 +6 +100%
LC
402
Lindbrook Capital
California
$480 -$1.46K -30 -77%
AAP
403
Arax Advisory Partners
Colorado
$427 -$682 -14 -64%
FCA
404
FinTrust Capital Advisors
South Carolina
$374
Kayne Anderson Rudnick Investment Management
405
Kayne Anderson Rudnick Investment Management
California
$373
VCM
406
Versant Capital Management
Arizona
$213 -$9.89K -203 -98%
TWP
407
TFO Wealth Partners
Ohio
$107
PCMC
408
Planning Capital Management Corporation
Pennsylvania
$54 +$49 +1 New
NI
409
Nuance Investments
Missouri
-$180M -3,620,518 Closed
HRCM
410
Hawk Ridge Capital Management
California
-$111M -2,225,772 Closed
D.E. Shaw & Co
411
D.E. Shaw & Co
New York
-$27.1M -546,754 Closed
TAL
412
TIG Advisors LLC
New York
-$18.6M -374,617 Closed
AAM
413
Alpine Associates Management
Florida
-$18.4M -369,865 Closed
Arrowstreet Capital
414
Arrowstreet Capital
Massachusetts
-$12.8M -258,819 Closed
ECM
415
ExodusPoint Capital Management
New York
-$9.86M -198,480 Closed
TC
416
TwinBeech Capital
New York
-$9.57M -192,737 Closed
Renaissance Technologies
417
Renaissance Technologies
New York
-$7.87M -158,518 Closed
Capital Fund Management (CFM)
418
Capital Fund Management (CFM)
France
-$5.25M -105,654 Closed
BGIM
419
Boussard & Gavaudan Investment Management
United Kingdom
-$4.44M -88,274 Closed
KC
420
Kepos Capital
New York
-$4.22M -85,000 Closed
WIC
421
Water Island Capital
New York
-$3.86M -77,756 Closed
KPF
422
K2 Principal Fund
Ontario, Canada
-$3.48M -70,103 Closed
ECM
423
Element Capital Management
New York
-$2.92M -58,888 Closed
QCM
424
Quantinno Capital Management
New York
-$2.63M -53,055 Closed
EGM
425
Engineers Gate Manager
New York
-$1.68M -33,819 Closed

GMED Hedge Fund Activity: Q4 2023 in Review

408 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2023, worth a combined $5.72B — up 5.3% from $5.43B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of GMED and 51 opened new positions — a net loss of 14 holders — while 164 trimmed existing stakes and 132 added.

The largest buyer was Millennium Management, adding an estimated $80.5M. The largest seller was Nuance Investments, exiting entirely with an estimated $180M sold.

  • 408 institutional investors held Globus Medical (GMED) as of Q4 2023, down from 431 in Q3 2023.
  • Funds reported $5.72B of Globus Medical stock for Q4 2023, up 5.3% quarter-over-quarter.
  • 51 funds opened new Globus Medical positions in Q4 2023 and 65 closed out, a net change of -14 holders.
  • The largest Globus Medical buyer in Q4 2023 was Millennium Management, an estimated $80.5M added.
  • The largest Globus Medical seller in Q4 2023 was Nuance Investments, an estimated $180M sold.

Based on aggregated 13F filings for Q4 2023.